News
London stocks had pared gains by midday on Friday, with GSK under the cosh. The FTSE 100 was flat at 8,971.33, having ...
The FTSE 100 index was up just 4.95 points at 8,977.59. The FTSE 250 gained 109.90 points, 0.5%, at 21,876.33, and the AIM All-Share climbed 2.54 points, 0.3%, at 771.47.
Reckitt Benckiser shares have lifted 2% or 110p to 5092p after the consumer goods giant secured a private equity buyer for ...
London stocks ended higher on Friday, supported by a positive shift in investor sentiment following US consumer confidence ...
Hosted on MSN29d
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?For new and old investors, taking full advantage of the stock market and investing ... likelihood its share price will decline as well. Thus, the more stocks you own with a #1 or #2 Rank and Scores of ...
Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the company released ...
StockStory.org on MSN4d
QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To KnowA number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.
(Alliance News) - Stock prices in Europe opened higher early on Friday, with the FTSE 100 almost hitting a new record high, as a swathe of dealmaking was well-received in London. The FTSE 100 index ...
The fallers board was led by WPP, which slumped by 16% to its lowest level since 2009 after the marketing and advertising ...
Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President ...
Britain launched a life sciences sector plan on Wednesday to a mixed response from the pharmaceutical industry, which welcomed proposals to boost R&D but warned it would fail to keep firms competitive ...
5d
Clinical Trials Arena on MSNUK Government targets manufacturing as it eyes £41bn life science sector growthWith the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results